Patrys (ASX:PAB) Machinery, Furniture, Equipment : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Patrys Machinery, Furniture, Equipment?

Patrys's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Patrys's quarterly Machinery, Furniture, Equipment declined from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.00 Mil).

Patrys's annual Machinery, Furniture, Equipment stayed the same from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

Patrys Machinery, Furniture, Equipment Historical Data

The historical data trend for Patrys's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patrys Machinery, Furniture, Equipment Chart

Patrys Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

0.01

Patrys Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Patrys Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Patrys (ASX:PAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Patrys Ltd (ASX:PAB) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.patrys.com

Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.